Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

25%

Ph phase_1

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

Phase 2Efficacy & side effects

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (75.0%)

Phase 21 (25.0%)

Trials by Status

not_yet_recruiting125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

not_yet_recruitingphase_1

A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults

NCT07697846

completedphase_1

A Study of ZT002 Injection in Participants With Overweight or Obesity

NCT06371326

completedphase_2

A Study of ZT002 Injection With Subjects With Overweight or Obesity

NCT07020884

completedphase_1

A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT07065032

Clinical Trials (4)

Showing 4 of 4 trials

NCT07697846Phase 1

A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults

Not Yet Recruiting

NCT06371326Phase 1

A Study of ZT002 Injection in Participants With Overweight or Obesity

Completed

NCT07020884Phase 2

A Study of ZT002 Injection With Subjects With Overweight or Obesity

Completed

NCT07065032Phase 1

A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4